Tenax Therapeutics (TENX) Gross Margin (2011 - 2013)
Tenax Therapeutics (TENX) posted quarterly Gross Margin of 20.52% for Q2 2013, up 1495.0% year-over-year from 1.29% in Q2 2012, and up 3312.47% on a QoQ basis from 0.6% in Q1 2013.
Tenax Therapeutics (TENX) Gross Margin (2011 - 2013) Analysis & Trends
Tenax Therapeutics has reported Gross Margin for 4 years, with the latest figure at 20.52% in Q2 2013.
- Gross Margin for Q2 2013 came in at 20.52%, up 1495.0% year-over-year; the trailing twelve-month figure through Dec 2015 was 19.07% (changed N/A YoY), and the FY2014 annual result was 39.57%, down 4373.0% from the prior year.
- Gross Margin rose to 20.52% in Q2 2013, from 0.6% in the prior quarter.
- Over five years, Gross Margin peaked at 100.0% in Q4 2010 and troughed at 0.6% in Q1 2013.
- A 4-year average of 40.82% and a median of 17.78% in 2011 frame the typical range for Gross Margin.
- The widest annual swing landed in 2012, when Gross Margin slumped 9854 bps; it then jumped 1495 bps in 2013.
- A 4-year view of Gross Margin shows it stood at 100.0% in 2010, then tumbled by 82 bps to 17.78% in 2011, then plunged by 94 bps to 1.06% in 2012, then surged by 1843 bps to 20.52% in 2013.
- Per Business Quant data, the three most recent Gross Margin figures were 20.52% in Q2 2013, 0.6% in Q1 2013, and 1.06% in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | Tenax Therapeutics | 80.73 Mn | 80.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 28.22% |
| Jan 31, 2013 | 0.60% |
| Oct 31, 2012 | 1.07% |
| Jul 31, 2012 | 2.08% |
| Apr 30, 2012 | 5.57% |
| Jan 31, 2012 | 1.48% |
| Oct 31, 2011 | 31.69% |
| Jul 31, 2011 | 100.00% |
| Apr 30, 2011 | 100.00% |